Wealth Manager - the site for professional investment managers

Register free for our breaking news email alerts with analysis and cutting edge commentary from our award winning team. Registration only takes a minute.

Big pharma is the replacement for lost income, says Ecclesiastical

If we can't rely on the banks and oil majors for dividend growth, what then? Ketan Patel, socially responsible investing (SRI) analyst at Ecclesiastical, argues the pharmaceutical sector is worth another look.

Patel says that while the sector has come under pressure in the last few years, the emergence of a medicine-buying middle class in developing economies spells good news for Western drug companies.

Not only are pharmaceuticals trading at attractive prices, Patel argues the sector makes sense for ethically-minded investors, singling out GlaxoSmithKline for its work in providing developing nations with access to medicine.

Ecclesiastical's Robin Hepworth, AAA-rated by Citywire, runs the Ecclesiastical Higher Income and Ecclesiastical Amity International funds. Both feature in Citywire Selection, the guide to our best investment ideas.

Filmed by Ecclesiastical.

Leave a comment!

Please sign in or register to comment. It is free to register and only takes a minute or two.

Related Fund Managers

Robin Hepworth
Robin Hepworth
353/446 in Equity - Global (Performance over 3 years) Average Total Return: 26.75%
Your Business: Cover Star Club

Profile: how career burnout led to a family office launch

Profile: how career burnout led to a family office launch

I was burnt-out from a career in finance and had no desire to come back, says the founder of Blu Family Office

Wealth Manager on Twitter